PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
9024236-9	1997	Compared to those on the control day, a significant rise in the integrated PRA levels occurred on the first day of nifedipine treatment, with a further rise observed on the eighth day of the treatment in the normotensive subjects (1.1 +/- 0.6, 1.7 +/- 1.2, and 2.5 +/- 1.8 ng/mL.h on the control day and the first and eighth days of treatment, respectively; P < 0.05) and by the eighth day in the hypertensive subjects (2.2 +/- 2.8 and 4.0 +/- 4.1 ng/mL.h; P < 0.05).	Nifedipine	115-125	S100 calcium binding protein A6	Homo sapiens	75-78	
9024236-12	1997	When individual time points were examined in the normotensive subjects, Aldo/PRA levels were significantly lower on day 8 of nifedipine treatment at 1000, 1200, and 1400 h than corresponding values on the control day.	Nifedipine	125-135	S100 calcium binding protein A6	Homo sapiens	77-80	
9024236-13	1997	The fall in the Aldo/PRA ratio during nifedipine treatment indicates that the previously reported in vitro inhibition of Aldo biosynthesis in adrenal cells is reproduced in vivo.	Nifedipine	38-48	S100 calcium binding protein A6	Homo sapiens	21-24	
2765972-5	1989	In 4 elderly women (61-77 yrs), PRA level after nifedipine tended to rise, no such trend was observed for aldosterone.	Nifedipine	48-58	S100 calcium binding protein A6	Homo sapiens	32-35